MedTechHub · Surgical & Implants · Asia Pacific

China Endoscopy Devices Market Size, Share - Growth Analysis Report and Forecast Trends 2026-2030

The China endoscopy devices market represents the medical equipment sector dedicated to instruments used for minimally invasive diagnostic and surgical procedures, including endoscopes, laparoscopes, arthroscopes, and related accessories. Valued at approximately $4.84 billion in 2025, the market is projected to grow at a compound annual growth rate of 10.98%, driven primarily by an aging population, rising prevalence of chronic gastrointestinal and other diseases, and a national shift toward minimally invasive surgical techniques. Expansion is further fueled by technological advancements in endoscopic imaging, increasing healthcare infrastructure investment, and growing domestic manufacturing capabilities under China's medical device localization policies.

Market size · 2025
$4.8 billion
CAGR · 2025–2030
10.98%
Forecast · 2030
$8.1 billion
Basis
Claight Analysis
Market size (USD)
Base year 2025
Official data · Claight AnalysisForecast
Market size and forecast are Claight Analysis, informed by public research.
Forecast
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2025 base: $4.8bn2030 est: $8.1bn
Read the full China Endoscopy Devices Market report →

Market Overview

The China endoscopy devices market encompasses a wide range of medical instruments used for internal examination and minimally invasive procedures across gastroenterology, pulmonology, arthroscopy, laparoscopy, and urology. With an estimated market value of $4.84 billion in 2025, it stands as one of the largest endoscopy markets in the Asia Pacific region. The market is segmented by product type, including flexible endoscopes, rigid endoscopes, laparoscopes, arthroscopes, and cystoscopes, as well as by application, end-user (hospitals, ambulatory surgical centers, and specialty clinics), and geography across China's diverse regional healthcare landscapes.

  • Market covers endoscopes, laparoscopes, arthroscopes, and related devices for minimally invasive diagnostics and surgery
  • Valued at approximately $4.84 billion in 2025 with a projected CAGR of 10.98%
  • Segmented by device type, application, and end-user across China's regional healthcare systems

Growth Drivers

The market's robust expansion is anchored by China's aging demographic, which has significantly increased the incidence of chronic diseases such as gastrointestinal disorders, cancers, and cardiovascular conditions that require endoscopic diagnosis and intervention. The clinical preference for minimally invasive procedures, which reduce patient recovery time, hospital stays, and complication rates, has driven hospital adoption of advanced endoscopic systems. Additionally, China's government has prioritized healthcare infrastructure modernization, expanded medical insurance coverage, and promoted domestic medical device manufacturing, all of which have reduced reliance on imports and lowered costs for healthcare providers.

  • Rising prevalence of chronic gastrointestinal diseases and cancers increases demand for endoscopic diagnostics
  • Growing preference for minimally invasive surgeries over open procedures accelerates market adoption
  • Government healthcare infrastructure investment and medical device localization policies support domestic market growth
Want a deeper cut on China Endoscopy Devices Market? We build bespoke studies on request.
Connect to an analyst →

Segmentation and Regional Analysis

The market is broadly divided into flexible endoscopes, rigid endoscopes, and accessories, with flexible endoscopes representing the largest segment due to widespread use in gastrointestinal endoscopy. Laparoscopes and arthroscopes are gaining share as minimally invasive surgical volumes increase. Geographically, Eastern China, anchored by Shanghai, Beijing, and Jiangsu Province, dominates the market due to superior healthcare infrastructure, higher per-capita healthcare spending, and concentration of major hospitals. Western and Central China are emerging growth regions as the government invests in regional medical facilities and expands healthcare access in Tier 3 and Tier 4 cities.

  • Flexible endoscopes lead the product segment, followed by rigid endoscopes and surgical scopes like laparoscopes
  • Eastern China leads in market share, with growing contributions from Central and Western regions
  • Ambulatory surgical centers and specialty clinics are expanding end-user diversification beyond traditional hospitals

Trends and Outlook

What are the recent trends and outlook?

The market is being reshaped by several key trends, including the integration of artificial intelligence and machine learning into endoscopic imaging systems for improved lesion detection and diagnostic accuracy. Capsule endoscopy and single-use endoscopes are gaining adoption due to infection control concerns and procedural convenience. The push for digital endoscopy with high-definition imaging and real-time data analytics is accelerating product innovation cycles. Looking ahead, the market is expected to sustain double-digit growth through 2030 as China continues expanding healthcare access, embracing advanced medical technologies, and reducing the cost gap between imported and domestically produced endoscopy devices.

  • AI-assisted endoscopy and digital imaging systems are transforming diagnostic capabilities and procedural precision
  • Single-use and capsule endoscopy technologies are growing due to infection control priorities
  • The market is expected to sustain strong growth through 2030, driven by healthcare access expansion and domestic manufacturing advancement
Talk to a Claight analyst
Do you want to research China Endoscopy Devices Market?

Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.

Connect to an analyst →

Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.